TAKEDA PHARMACEUTICAL CO LTD (TKPHF) Financials
TKPHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 100.9 billion | 53.0 billion |
| 2023-09-30 | 99.6 billion | 52.2 billion |
| 2023-06-30 | 102.3 billion | 54.5 billion |
| 2023-03-31 | 105.1 billion | 57.2 billion |
TKPHF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 491.6 million | 132.6 million |
| 2023-09-30 | 862.7 million | 124.1 million |
| 2023-06-30 | -1.2 billion | 106.8 million |
| 2023-03-31 | -1.1 billion | 111.8 million |
TKPHF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 749.9 million |
| 2023-09-30 | -321.1 million |
| 2023-06-30 | 618.5 million |
| 2023-03-31 | 234.4 million |
TKPHF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 2.3 billion | - | - |
| 2023-09-30 | 2.2 billion | - | - |
| 2023-06-30 | 2.6 billion | - | - |
| 2023-03-31 | 4.2 billion | - | - |
TKPHF Shares Outstanding
TKPHF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 546.9 million | 1.3 billion | 1.9 billion | - |
| 2023-09-30 | 468.9 million | 1.2 billion | 1.7 billion | - |
| 2023-06-30 | 1.9 billion | 1.1 billion | 1.7 billion | - |
| 2023-03-31 | 3.3 billion | 1.2 billion | 1.9 billion | - |
TKPHF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 7.9 billion | 2.7 billion |
| 2023-09-30 | 7.0 billion | 2.3 billion |
| 2023-06-30 | 7.3 billion | 2.2 billion |
| 2023-03-31 | 7.2 billion | 2.3 billion |
TKPHF
Price: $26.06
Dividend Yield: 6.94%
Forward Dividend Yield: 10.73%
Payout Ratio: 372.85%
Dividend Per Share: 2.80 USD
Earnings Per Share: 0.74 USD
P/E Ratio: 37.41
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1
Market Capitalization: 42.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: -7.68%
DGR5: 30.00%
DGR10: 30.00%